[Featured Stock] JinMatrix Rises for Second Day as Nasdaq Listing of Stakeholder 'Baeksitek' Advances
[Asia Economy Reporter Park Jihwan] Jin Matrix is showing a strong performance for the second consecutive day following the previous day's limit-up, after the news of the Nasdaq listing of the UK vaccine developer Vaxcyte on the 9th.
As of 10:06 AM on this day, Jin Matrix recorded 14,950 won, up 850 won (6.03%) compared to the previous day. On the previous day, it closed at 14,100 won after rising to the price limit. The news of Vaxcyte, which holds about a 5% stake, listing on Nasdaq acted as a positive factor.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- Blue House Protests Bloomberg's "Distorted Reporting on AI National Dividend"
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
According to major foreign media, Vaxcyte is currently pursuing a Nasdaq listing. Vaxcyte is a vaccine developer spun off from the University of Oxford in the UK. Jin Matrix invested 4 million pounds (approximately 6.1 billion won) in Vaxcyte in 2018.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
